Phagenyx provides treatment therapy for stroke patients experiencing difficulty in swallowing.
Restoring this neurological pathway negates intubating the patient, providing them the independence to return home more quickly; and to eat and drink safely.
Restoring this neurological pathway negates intubating the patient, providing them the independence to return home more quickly; and to eat and drink safely.
The touch-screen user-interface was designed in close collaboration with the client, for clarity and comprehension by clinicians; as well as a look-and-feel consistent with the Phagenesis brand and hardware enclosure.
As a portable device, consideration was given to patterns and environments of use, and ultimately assets output for clinical trial and ISO 13485 certification.
As a portable device, consideration was given to patterns and environments of use, and ultimately assets output for clinical trial and ISO 13485 certification.
All © Phagenesis
